MSYS.L

Microsaic Systems Plc
Microsaic Systems - Company Update
25th June 2024, 07:06
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 7571T
Microsaic Systems plc
25 June 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION

 

FOR IMMEDIATE RELEASE

 

 

Microsaic Systems plc

 

("Microsaic" or the "Company")

                                  

Company update

 

Microsaic Systems plc (AIM: MSYS), the developer of microelectronic instruments and provider of integrated Modern Water analytical solutions, is pleased to announce the following update.

 

Research & Development Tax Credit                                                                                                                                    

 

The Company is also pleased to announce it has now received a research and development tax credit from HMRC in the amount of £262,000 for qualifying costs expended in 2022. These costs primarily relate to research and development work by the Company on the pathogen detector for identifying Covid-19 in water. As previously announced, the Company is further developing a device to identify and monitor a wide range of pathogens in water, by adapting the Covid-19 model into an online multi-pathogen detector capable of delivering rapid results.

 

Business Restructuring

 

Having restructured the business at the turn of the year, the Board remains committed to the Company's reset objectives starting this year and to applying a business plan built on the integration of the Microsaic Systems and Modern Water technologies. This technical integration for water testing services is now branded and marketed as 'Tethys Purity' to reflect the broad and comprehensive water testing capabilities that the Company can now offer. Tethys Purity is a modular concept where customers can select the entire suite or a range of devices and services to meet their specific needs, from PFAS detection to toxic water monitoring including pathogen identification. The Company is actively building up partnerships and joint ventures to support its commercial objectives to deliver a total solution for water testing and safety.

 

Bob Moore, Acting Executive Chairman of Microsaic, commented:

 

"We are moving the Company forward by building on our newly combined technologies and enhanced business capabilities. We look forward to completing our worthwhile projects as part of our wider objective of growth and business development, and to building mutually rewarding partnerships to create value for our investors."

 

 

Microsaic Systems plc

Bob Moore, Acting Executive Chairman

+44 (0) 20 3657 0050

via TPI

 

 

Singer Capital Markets (Nominated Adviser)

Aubrey Powell / Oliver Platts

+44 (0)20 7496 3000

 

 

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

 

About Microsaic Systems and Modern Water

Microsaic is highly experienced in microelectronics and development of instrumentation. Having acquired the Modern Water business it has reset, diversified and widened its capabilities into broader based analytical equipment supply and services company with combined technologies resulting in comprehensive water testing capabilities. The Company has an extensive existing and newly acquired innovative patent portfolio in industry-leading technology designed and developed for "Industry 4.0" application serving markets in diversified Industries, Human and Environmental Health. Microsaic's micro-mass spectrometer system and water testing solutions enables analytical detection and characterisation at the point-of-need, whether within a mobile testing capability, conventional laboratory setting, or within a bioprocessing facility for continuous detection of data at multiple steps in the process workflow.

 

Microsaic's products and solutions are commercially available through global markets via a network of regional and local partners, targeting its core laboratory, manufacturing and point-of-need applications.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDUVRBRSSUNURR]]>
TwitterFacebookLinkedIn